Shanghai Labway Clinical Laboratory Co Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

2.19

EPS

—

Div Yield, %

3.73%

Shrs. gr., 5y

2.59%

Rev. gr., 5y

9.73%

Revenues

1.67b

-60.13%

Net income

-142m

CFO

547m

+549.88%

Dividend

Jun 20, 20230.3 CNY/sh

Profile

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

URL

https://www.labway.cn/

IPO date

Sep 13, 2021

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	1,674,369 -60.13%	4,199,305 136.14%
Cost of revenue	1,493,568	2,792,924
Unusual Expense (Income)
NOPBT	180,801	1,406,381
NOPBT Margin	10.80%	33.49%
Operating Taxes	8,466	165,388
Tax Rate	4.68%	11.76%
NOPAT	172,334	1,240,993
Net income	(141,591) -122.94%	617,323 202.85%
Dividends	(136,709)
Dividend yield	2.57%
Proceeds from repurchase of equity	(10,255)
BB yield	0.19%
Debt
Debt current	181,863	166,244
Long-term debt	187,904	91,236
Deferred revenue	11,942	14,681
Other long-term liabilities	5,088
Net debt	(505,498)	(425,072)
Cash flow
Cash from operating activities	546,988	84,167
CAPEX	(398,885)
Cash from investing activities		180,053
Cash from financing activities	44,726	50,485
FCF	495,239	382,809
Balance
Cash	861,201	665,813
Long term investments	14,064	16,739
Excess cash	791,547	472,587
Stockholders' equity	1,350,587	1,718,794
Invested Capital	1,554,349	1,959,318
ROIC	9.81%	85.15%
ROCE	7.71%	57.83%
EV
Common stock shares outstanding	400,542	400,517
Price	13.29 -32.23%	19.61 -43.54%
Market cap	5,323,198 -32.22%	7,854,138 -43.54%
EV	5,018,202	7,638,555
EBITDA	246,165	1,484,621
EV/EBITDA	20.39	5.15
Interest	8,170	8,458
Interest/NOPBT	4.52%	0.60%